Validation of Diagnostic Codes to Identify Carbon... (2022 study) Skip to main content
Cohort Study Front Pharmacol 2022

Validation of Diagnostic Codes to Identify Carbon Monoxide Poisoning in Taiwan's Claims Data

Chiang M, Shao S, Liao S, Front Pharmacol, 2022

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers checked how well hospital diagnosis codes for carbon monoxide poisoning matched what doctors found in medical records, using Taiwan's health insurance claims data.

What They Found

In this validation study of Taiwan claims data, diagnosis codes alone did not accurately identify carbon monoxide poisoning, but accuracy improved when hyperbaric oxygen therapy during hospitalization was added to the code. The team reviewed a random sample of 557 cases from 5,571 patients who newly had a carboxyhemoglobin blood test at four hospitals from 2011 to 2020. For ICD-9-CM code 986, sensitivity was 90.9% and positive predictive value was 72%. For ICD-10-CM code T58, sensitivity was 94.9% and positive predictive value was 76.6%. Positive predictive value was higher when poisoning was the primary diagnosis, and it could reach 100% when patients with either code also received hyperbaric oxygen therapy during hospitalization.

What This Means for Canadian Patients

This study is about the accuracy of billing and diagnosis codes, not about how well any treatment works. It does not report patient outcomes after hyperbaric oxygen therapy. It shows that when researchers use claims data to find carbon monoxide poisoning cases, receipt of hyperbaric oxygen therapy during hospitalization was one data point that made case identification more accurate.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The study used a 10% sample from four hospitals in one country, and only patients who had a carboxyhemoglobin test were included, so the results may not apply to other settings or to poisoning cases that were never tested.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Cohort Study
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 35784736
Year Published 2022
Journal Front Pharmacol

Cite This Study

Share

This study relates to Carbon Monoxide Poisoning. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology